Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Clinical trial NCT05287945 · RECRUITING
Trial details
- NCT number
- NCT05287945
- Sponsor
- Oncorena AB
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-04
- Primary completion
- 2027-12-31
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.